Management and outcomes of severe dengue patients presenting with sepsis in a tropical country

Background Dengue is a common cause of infection in adults in tropical countries. Sepsis is a syndrome of systemic manifestations induced by infection of any organisms; including bacterial, fungal and viral agents. Here, we investigated the diagnosis, management and outcomes of dengue patients presenting with sepsis in a prospective study of community-acquired sepsis in Thailand. Methods From June to December 2015, 874 adult patients (age≥18 years) with suspected or documented community-acquired infection, with ≥3 diagnostic criteria for sepsis according to the Surviving Sepsis Campaign 2012, and within 24 hours of admission were evaluated. Serum was stored and later tested for dengue PCR assays. Results A total of 126 patients had dengue PCR assays positive (2 DENV-1, 12 DENV-2, 24 DENV-3 and 88 DENV-4), and 5 of them (4%) died. We found that attending physicians suspected dengue infection on admission in 84 patients (67%), and recorded dengue infection as the final diagnosis in 96 patients (76%). Four of five fatal cases were diagnosed and treated as septic shock not due to dengue. In multivariable analysis, there was a trend showing that age≥60 years, hypoxemia and misdiagnosis of dengue by attending physicians were associated with 28-day mortality. Conclusions A number of adult patients who died of dengue are misdiagnosed as severe sepsis and septic shock. Diagnosis of dengue based on clinical features alone is difficult. Rapid diagnostic tests for dengue may need to be routinely used in adult patients presenting with sepsis and septic shock in tropical countries. This approach could improve diagnosis and management of those patients.

[1]  A. Nisalak,et al.  Incidence of Dengue Virus Infection in Adults and Children in a Prospective Longitudinal Cohort in the Philippines , 2016, PLoS neglected tropical diseases.

[2]  A. Teeraratkul,et al.  Changing epidemiology of dengue hemorrhagic fever in Thailand , 1999, Epidemiology and Infection.

[3]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[4]  D. Moore,et al.  The global diabetes epidemic: what does it mean for infectious diseases in tropical countries? , 2016, The Lancet Diabetes & Endocrinology.

[5]  N. M. Dung,et al.  Clinical Characteristics of Dengue Shock Syndrome in Vietnamese Children: A 10-Year Prospective Study in a Single Hospital , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Fisher,et al.  Dengue mortality: reassessing the risks in transition countries. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[8]  adult illness IMAI district clinician manual : hospital care for adolescents and adults : guidelines for the management of common illnesses with limited resources , 2011 .

[9]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[10]  E. Ooi,et al.  Dengue: an update on treatment options. , 2015, Future microbiology.

[11]  A. Hoes,et al.  The changing incidence of Dengue Haemorrhagic Fever in Indonesia: a 45-year registry-based analysis , 2014, BMC Infectious Diseases.

[12]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[13]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[14]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[15]  H. Gómez-Dantés,et al.  Clinical profile of dengue hemorrhagic fever cases in Mexico. , 2005, Salud publica de Mexico.

[16]  Alan L Rothman,et al.  Spatial and Temporal Clustering of Dengue Virus Transmission in Thai Villages , 2008, PLoS medicine.

[17]  P. Pallavi,et al.  Evaluation of Platelets as Predictive Parameters in Dengue Fever , 2011, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion.

[18]  J. Olson,et al.  Etiology of Acute, Non-Malaria, Febrile Illnesses in Jayapura, Northeastern Papua, Indonesia , 2012, The American journal of tropical medicine and hygiene.

[19]  U. Thisyakorn,et al.  DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT. , 2015, The Southeast Asian journal of tropical medicine and public health.

[20]  Y. Leo,et al.  Critical care for dengue in adult patients: an overview of current knowledge and future challenges , 2016, Current opinion in critical care.

[21]  C. Rodrigo,et al.  Treatment of dengue fever , 2012, Infection and drug resistance.

[22]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[23]  A. d’Arminio Monforte,et al.  Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern , 2017, Infection.

[24]  K. Tomashek,et al.  Utility of the Tourniquet Test and the White Blood Cell Count to Differentiate Dengue among Acute Febrile Illnesses in the Emergency Room , 2011, PLoS neglected tropical diseases.

[25]  J. M. Peralta,et al.  Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region , 2011, Journal of the Neurological Sciences.

[26]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[27]  Simon I Hay,et al.  The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[28]  Margaret M Parker,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[29]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[30]  Cameron P. Simmons,et al.  Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[32]  X. de Lamballerie,et al.  Causes of non-malarial fever in Laos: a prospective study , 2013, The Lancet. Global health.

[33]  C. Hor,et al.  A Two-Year Review on Epidemiology and Clinical Characteristics of Dengue Deaths in Malaysia, 2013-2014 , 2016, PLoS neglected tropical diseases.

[34]  D. Firth Bias reduction of maximum likelihood estimates , 1993 .

[35]  Nicholas J White,et al.  Comparison of three fluid solutions for resuscitation in dengue shock syndrome. , 2005, The New England journal of medicine.

[36]  Y. Leo,et al.  Risk factors for concurrent bacteremia in adult patients with dengue. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.